About Slate Bio
Slate Bio is a private company based in Charlottesville, Virginia, incorporated in 2020 in Delaware. It has reported $4,776,905 raised in two offerings on Form D since June 2021. Its chief executive is Andrew Krouse.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 30, 2022 | Jan 17, 2023amended May 25, 2023 | $2,776,949of $3.0M target | 9 | $308K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 24, 2020 | Jun 3, 2021 | $1,999,956fully sold | 10 | $199K | Equity, Offer and sale of shares of preferred stock and the underlying shares of common stock issuable upon conversion thereof.Rule 506(b) | Form D ↗ |
| Total, two offerings | $4,776,905 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Slate Bio's Form D filed May 25, 2023.
Andrew Krouse
Chief Executive Officer and director
Also a founder, president & chief executive officer, director at Navion Neurosciences.
KW
Kurt Woerpel
Executive officer
RC
Robert Creeden
Director
KS
Kyparissia Sirinakis
Director
BG
Brian Gallagher
Director